Seed DS-01 Alternatives: Cheaper Probiotics, Named Strains
Not medical advice. Strain, count and serving are each brand’s own label or listing; prices are current Amazon prices for the exact pack. Probiotics are strain-specific: a trial result belongs to the strain that was tested, at the dose that was tested. Anyone immunocompromised or seriously ill should ask a clinician before any live-organism product.
Quick answer
Seed DS-01 declares 24 strains and 53.6 billion AFU per two capsules at $2.00 a day, and its listing names none of them. A cheaper alternative is a product that names one strain with a trial behind it: Culturelle Daily Probiotic (10 billion CFU L. rhamnosus GG, $0.58 a day) and Florastor Daily Probiotic (250 mg S. boulardii, $0.80) carry Cochrane-level evidence for antibiotic-associated diarrhea; Schiff Digestive Advantage Daily Probiotic is cheapest at $0.30 on a preliminary IBS trial.
Buy the strain for the job, or buy nothing. The 7 named-strain products we track cost $0.30 to $1.23 a day against Seed’s $2.00; none of them, and not Seed, has a trial for “general gut health”. Of 819 probiotic labels we read, only 8.8% even state a CFU quantity. See every named-strain alternative ranked →
On this page
Every named-strain probiotic we track, ranked by cost per day, with Seed for comparison
Product links go to Amazon and we may earn a commission if you buy. It never changes which product we pick or what we say about it. How we choose.
Cost per day is the current Amazon price divided by servings, one serving a day. Strain and count are as each label states them; the evidence tier is the strongest study we have verified for that exact strain, named in the next column. Seed is the last row, at its own declared count.
| Product | Per day | Strain named on label | Count per serving | Evidence | What the trials tested | Who it is for | Buy |
|---|---|---|---|---|---|---|---|
 Schiff Digestive Advantage Daily Probiotic | $0.30 | Bacillus coagulans GBI-30, 6086 | 2 billion CFU per 1 capsule | Preliminary RCT | IBS pain and bloating in a 44-patient trial the authors called preliminary | IBS, cautiously | Check price |
 Culturelle Daily Probiotic | $0.58 | Lactobacillus rhamnosus GG | 10 billion CFU per 1 capsule | Cochrane / meta-analysis | Antibiotic-associated diarrhea: 8% vs 19% across 23 pediatric trials | Adults and children on antibiotics | Check price |
 Culturelle Kids Purely Probiotics Chewables | $0.68 | Lactobacillus rhamnosus GG | 5 billion CFU per 1 chewable | Cochrane / meta-analysis | The pediatric antibiotic-diarrhea strain, in a chewable | Children 3+ on antibiotics | Check price |
 BioGaia Protectis Baby Drops | $0.70 | Lactobacillus reuteri DSM 17938 | 0.1 billion CFU per 5 drops | Meta-analysis, infants | Infant colic: 25.4 min less crying a day across 4 trials, breastfed infants | Breastfed infants with colic | Check price |
 Florastor Daily Probiotic | $0.80 | Saccharomyces boulardii CNCM I-745 | 250 mg per 1 capsule | Cochrane / meta-analysis | Antibiotic-associated diarrhea 18.7% to 8.5% across 21 trials; traveler's diarrhea | On antibiotics; travel | Check price |
 Florastor Kids Probiotic Powder | $0.93 | Saccharomyces boulardii CNCM I-745 | 250 mg per 1 stick | Cochrane / meta-analysis | The yeast from the pediatric antibiotic-diarrhea trials, as a stick | Children on antibiotics | Check price |
 Visbiome High Potency Probiotic | $1.23 | De Simone formulation (8 strains) | 112.5 billion CFU per 1 capsule | Large RCT + guideline | Ulcerative colitis response 63.1% vs 40.8% at 3,600 billion CFU a day; pouchitis | Diagnosed UC or pouchitis, with a clinician | Check price |
 Seed DS-01 Daily Synbiotic | $2.00 | 24 strains, not named on the listing | 53.6 billion AFU per 2 capsules | Brand trial, not on file | The listing claims a bloating and gas trial and does not cite it | General gut health, no diagnosed condition | Check price |
The shaded rows are the strains with a Cochrane review or a meta-analysis behind them, and they are the cheap ones: Culturelle Daily Probiotic and Florastor Daily Probiotic cost $0.58 and $0.80 a day against Seed’s $2.00. The one strain with a large IBS trial, Bifidobacterium infantis 35624 (362 women; Whorwell 2006, PMID 16863564), is not in the table because the product that carries it currently has no buyable Amazon listing, and we do not substitute another strain for a strain-specific result.
What Seed DS-01 declares, and what it does not
On the record we can read, Seed DS-01 is 53.6 billion AFU across 24 strains per 2 capsules, 30 servings a pack, in a capsule-in-capsule with a prebiotic outer shell, sold as a “daily synbiotic” for $59.99 a month. AFU, active fluorescent units, is a flow-cytometry count of viable cells rather than the colony-forming units most labels use; the two are not interchangeable, and neither is evidence. The Amazon listing says the formula was shown to improve regularity and reduce bloating and gas in “the largest clinical trial for a probiotic on bloating and gas in healthy adults at the time of publication”; it does not cite the trial, we have not located and verified it, and so this page does not rate it. The listing names none of the 24 strains, and Seed has not filed a label with the NIH database that every other product on this page is read from. Seed publishes its strain list on its own site; what we can say from the label record is that none of the strains with the evidence in the table below, LGG, S. boulardii CNCM I-745, B. infantis 35624, L. reuteri DSM 17938, is one Seed’s listing names. The Seed vs Culturelle comparison goes through the delivery-tech claims.
The strain evidence, strain by strain
Lactobacillus rhamnosus GG (Culturelle Daily Probiotic, 10 billion CFU; Culturelle Kids Purely Probiotics Chewables for children) is the most-studied strain on the shelf. The Cochrane review of probiotics for pediatric antibiotic-associated diarrhea pooled 23 trials in 3,938 children: diarrhea in 8% on probiotics against 19% on control, relative risk 0.46, moderate-quality evidence, with LGG and S. boulardii the strains it singled out (Goldenberg 2015, PMID 26695080). In adults and children together, 63 randomized trials in 11,811 participants gave a relative risk of 0.58 and a number needed to treat of 13, with the authors noting that strains were poorly documented in most trials (Hempel 2012, PMID 22570464).
Saccharomyces boulardii CNCM I-745 (Florastor Daily Probiotic, 250 mg; the kids’ sticks are the same dose) is a yeast, which antibiotics cannot kill. Across 21 randomized trials in 4,780 people it cut antibiotic-associated diarrhea from 18.7% to 8.5%, relative risk 0.47, number needed to treat 10 (Szajewska 2015, PMID 26216624), and it is one of the two preparations with significant efficacy in the 12-trial meta-analysis of traveler’s diarrhea, where probiotics as a class had a relative risk of 0.85 (McFarland 2007, PMID 17298915).
Lactobacillus reuteri DSM 17938 (BioGaia Protectis Baby Drops, 0.1 billion CFU per five drops) is an infant product with adult-grade evidence for one thing: in an individual-participant meta-analysis of 4 double-blind trials in 345 infants with colic, it cut crying and fussing by 25.4 minutes a day at day 21, with a number needed to treat of 2.6 in breastfed infants and no significant effect in formula-fed infants (Sung 2018, PMID 29279326). The De Simone formulation (Visbiome High Potency Probiotic, 112.5 billion CFU, eight strains, refrigerated) is the multi-strain product with real trials, at doses far above one capsule: 144 patients with relapsing mild-to-moderate ulcerative colitis took 3,600 billion CFU a day or placebo for eight weeks, and 63.1% against 40.8% halved their disease-activity score (Tursi 2010, PMID 20517305); the American Gastroenterological Association conditionally recommends the eight-strain combination for pouchitis and makes no recommendation for irritable bowel syndrome (Su 2020, PMID 32531291). Bacillus coagulans GBI-30, 6086 (Schiff Digestive Advantage Daily Probiotic, 2 billion CFU) is the cheapest row and the thinnest: a 44-patient, 8-week trial in IBS found abdominal pain and bloating improved from baseline, analysed within groups because the groups differed at baseline, which the authors themselves called preliminary (Hun 2009, PMID 19332970). The best probiotic ranking and the strain matcher map each of these to a condition.
We read 896 probiotic labels: most do not state a count, and the median names 5 species
Original research900 on-market probiotic labels from the NIH Dietary Supplement Label Database on 2026-09-16, 896 analysed: 819 general labels and 77 marketed to women. Organisms are read from the Supplement Facts rows; a CFU count is counted only where it appears as a structured quantity. Every figure was recomputed in two halves within each population and only the ones that agreed are printed.
Only 8.8% of the 819 general probiotic labels state a structured CFU quantity, and the median label names 5 species. The women’s shelf is the same pattern with more marketing: 93.5% of the 77 women-marketed labels use a proprietary-blend row, so the count per strain is not stated; 14.3% name the GR-1 and RC-14 pair from the vaginal-health trials, and 2.6% name L. crispatus, against 0.5% of general labels. Seed is not in this database, so it is not in these figures; its 24-strain, unnamed-on-the-listing format is the shelf’s norm rather than an exception to it. What the shelf sells is species counts and blends; what the trials reward is one named strain at a stated dose.
| Item | Value (%) |
|---|---|
| Women's labels: proprietary-blend row | 93.5% |
| Women's labels naming GR-1 / RC-14 | 14.3% |
| General labels stating a CFU quantity | 8.8% |
| Women's labels naming L. crispatus | 2.6% |
| General labels naming L. crispatus | 0.5% |
How we read the labels, and what did not hold
Method: 900 labels from the NIH Dietary Supplement Label Database (DSLD) v9 searches for probiotic, women’s probiotic and probiotic for women, read on 2026-09-16; 896 analysed (819 general, 77 women-marketed by product name). Every check was recomputed in two halves split by label-id parity within its population: 6 of 9 held and only those are printed. Not printed (3): women's labels with a structured CFU quantity; women's labels adding cranberry / D-mannose; median species named, women's labels. The share of general labels naming L. rhamnosus GG was computed but not split-half checked, so it is not printed either. Product strain, count and serving are each label or listing as the catalog records them; cost per day is the current Amazon price divided by servings. The census is published as open data at /probiotics/seed-alternatives.json (CC BY 4.0). What it cannot tell you: how many viable organisms reach the colon from any product, whether a product contains what its label says, or Seed’s strain list, which is not on its listing or in the NIH database.
Which Seed alternative to buy
Visbiome High Potency Probiotic at $1.23 a day is the one multi-strain product with trials, and they are ulcerative colitis and pouchitis trials at many capsules a day, taken with a clinician; the IBS page and the antibiotic-diarrhea page pick by condition.
Frequently asked questions
What is a cheaper alternative to Seed DS-01?
A single-strain product whose strain has the trial for your problem. Culturelle Daily Probiotic is 10 billion CFU of Lactobacillus rhamnosus GG at $0.58 a day, 3.4 times cheaper than Seed's $2.00; Florastor Daily Probiotic is 250 mg of Saccharomyces boulardii at $0.80. Both have Cochrane-level evidence for preventing antibiotic-associated diarrhea, which Seed's listing does not claim. If you have no diagnosed condition, the cheapest alternative is not buying one.
What strains are in Seed DS-01?
Seed declares 24 strains and 53.6 billion AFU per two-capsule serving, in a capsule-in-capsule with a prebiotic outer shell. Its Amazon listing names none of the 24, Seed has not filed the label with the NIH Dietary Supplement Label Database, and we do not reproduce a strain list we cannot read from a label or listing. Seed publishes the list on its own site; the useful question is whether any strain on it carries a randomized trial for the outcome you want, and the listing cites none.
Is Seed better than Culturelle?
For a diagnosed job, no. Culturelle's single strain, L. rhamnosus GG, sits in the Cochrane review of 23 pediatric trials (antibiotic-associated diarrhea 8% on probiotics against 19% on control) and the 63-trial adult meta-analysis (relative risk 0.58, number needed to treat 13). Seed's 24-strain blend costs 3.4 times as much per day and the listing's trial claim is about bloating and gas in healthy adults, uncited. More strains and more AFU is a count, not evidence; efficacy in this category is strain-specific.
Does a higher CFU count mean a better probiotic?
No. The doses in the trials are the doses that worked: 10 billion CFU of LGG, 250 mg of S. boulardii, 3,600 billion of the De Simone formulation for ulcerative colitis, and 1 x 10^8 of B. infantis 35624 in the 362-woman IBS trial, where the 100-fold higher dose was no better than placebo. Of the 819 general probiotic labels we read in the NIH database, only 8.8% state a structured CFU quantity at all, and the median label names 5 species. A number on the front of the box tells you what was put in at manufacture, not what a trial found.
Which Seed alternative should I take with antibiotics?
Florastor Daily Probiotic or Culturelle Daily Probiotic, started with the first antibiotic dose and continued a week after. S. boulardii is a yeast, so the antibiotic cannot kill it and it can be taken at the same time; LGG is a bacterium and is taken two hours away from the antibiotic. In the meta-analyses, S. boulardii cut antibiotic-associated diarrhea from 18.7% to 8.5% across 21 trials and probiotics as a class cut it by about 42% across 63 trials. Ask a clinician first if you are immunocompromised or have a central line.
Related guides
- Probiotics: strains, conditions and what to buy
- Seed vs Culturelle
- Best probiotic, ranked by strain evidence
- Probiotic strain matcher
- Best probiotic for antibiotic diarrhea
- Best probiotic for IBS
- Probiotics for kids
- Probiotic dosage guide
Sources
- Goldenberg JZ, et al. “Probiotics for the prevention of pediatric antibiotic-associated diarrhea.” Cochrane Database Syst Rev. 2015. PMID: 26695080
- Hempel S, et al. “Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis.” JAMA. 2012. PMID: 22570464
- Szajewska H, Kołodziej M. “Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea.” Aliment Pharmacol Ther. 2015. PMID: 26216624
- McFarland LV. “Meta-analysis of probiotics for the prevention of traveler’s diarrhea.” Travel Med Infect Dis. 2007. PMID: 17298915
- Whorwell PJ, et al. “Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome.” Am J Gastroenterol. 2006. PMID: 16863564
- Sung V, et al. “Lactobacillus reuteri to Treat Infant Colic: A Meta-analysis.” Pediatrics. 2018. PMID: 29279326
- Tursi A, et al. “Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.” Am J Gastroenterol. 2010. PMID: 20517305
- Su GL, et al. “AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders.” Gastroenterology. 2020. PMID: 32531291
- Hun L. “Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS.” Postgrad Med. 2009. PMID: 19332970
- NIH Office of Dietary Supplements. Dietary Supplement Label Database. dsld.od.nih.gov (probiotic labels read 2026-09-16).
- Seed DS-01 Daily Synbiotic, Amazon listing (ASIN B0CMJR4XGR), features and price read via the Amazon Creators API on 2026-09-20.